(Press-News.org) The Lundquist Institute for Biomedical Innovation at Harbor-UCLA (TLI) announced today that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded a new grant (P01AI186818) to Dr. Ashraf S. Ibrahim, PhD, a TLI Investigator, a Professor of Medicine at David Geffen School of Medicine at UCLA, and a leading authority on mucormycosis pathogenesis. The grant provides $2.2 million in first-year funding and $11,269,858 million in total projected support over the next five years to launch MUCOR-ADVANCE, an ambitious effort to revolutionize risk stratification, early diagnosis, and treatment of mucormycosis, one of the world’s most lethal fungal infections.
MUCOR-ADVANCE unites three tightly integrated research projects supported by Clinical, Genomics/Transcriptomics, and Administrative Cores from TLI, MD Anderson Cancer Center, and University of Maryland. In addition to Dr. Ibrahim, the TLI team includes Dr. Scott Filler, MD, Dr. Priya Uppuluri, PhD, and Dr. Yiyou Gu, PhD. The MD Anderson team will be led by the internationally renowned clinician/Medical Mycologist Dr. Dimitrios Kontoyiannis, MD, ScD, PhD, Dr. Sebastian Wurster, MD, Dr. Teny John, MD , and Dr. Stephanie Watowich, PhD, while the University of Maryland team will be led by Dr. Vincent Bruno, PhD an internationally renowned expert in the field of mucormycosis omics research. The entire team will work to identify novel Mucorales toxins and invasins, decipher metabolic roadblocks, and leverage patient-derived samples to discover prognostic biomarkers and repurpose FDA-approved immunomodulators.
“This investment from NIAID validates two decades of collaborative research and positions us to finally outpace a disease that currently kills at least half of the patients it strikes,” said Dr. Ibrahim. “By unraveling how Mucorales fungi disarm the immune system, we aim to deliver rapid diagnostic tests and immune-based therapies that can save lives within this decade.”
A Coordinated, Multi-Institutional Assault on a Neglected Threat
Mucorales fungi cause mucormycosis is a fast-moving infection with an overall mortality rate of 50 percent, approaching 100 percent mortality in high-risk groups. Susceptible hosts include individuals with diabetic ketoacidosis, transplant recipients, those receiving intensive corticosteroid therapy, and those subjected to severe trauma. Despite rising incidence worldwide, progress has been slow and fragmented.
By combining fundamental mycology, cutting-edge immunology, and translational medicine, the team expects to deliver rapid diagnostics, host- and pathogen-directed immunotherapies, and evidence-based clinical algorithms to help stratify patients and tailor therapeutic interventions.
“These studies will not only save lives threatened by mucormycosis but also establish new paradigms for tackling other emerging fungal pathogens,” said Joe W. Ramos, PhD, President & CEO of TLI. “We are proud of Dr. Ibrahim’s visionary leadership and grateful to NIAID for its confidence in our institute’s mission to accelerate translational discoveries that will save lives worldwide.”
About The Lundquist Institute
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (TLI) is a leading nonprofit research organization in the life sciences ecosystem of Los Angeles County. Our bedside to bench to bedside approach is at the core of who we are and what differentiates us. Learn more at lundquist.org.
Acknowledgment & Disclaimer
Research reported in this press release is supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number P01AI186818. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Media Contact:
Jennifer Strong, AVP, Communications & Marketing
The Lundquist Institute for Biomedical Innovation
media@lundquist.org | 310-974-9300
END
The Lundquist Institute wins multi-year NIH grant exceeding $11 million to transform diagnosis and treatment of deadly mucormycosis
2025-07-15
ELSE PRESS RELEASES FROM THIS DATE:
Review suggests ending adult boosters for tetanus, diphtheria
2025-07-15
The United States could safely drop tetanus and diphtheria booster shots for adults and save an estimated $1 billion a year, according to a new review led by researchers at Oregon Health & Science University.
The safety and savings depend on maintaining strong childhood vaccination rates, researchers emphasized.
“By maintaining high childhood vaccination coverage, we not only protect kids, but we may actually be able to reduce adult booster vaccinations,” said lead author Mark Slifka, Ph.D., professor of microbiology and immunology in the OHSU School of Medicine and the Oregon National Primate Research Center. “That would save $1 billion a year in the U.S. while maintaining ...
ESMT Berlin welcomes Rebecca Schaumberg to faculty
2025-07-15
On July 1, 2025, Rebecca Schaumberg joined ESMT Berlin as an assistant professor of organizational behavior.
Rebecca Schaumberg’s research combines psychological theory with business practice and focuses on the role of self-conscious emotions such as shame, guilt, pride, and embarrassment in organizational contexts. Her work shows how these emotions shape decision-making, leadership processes, and organizational cultures. Her research has been published in leading academic journals, including Psychological Science, Academy of Management Journal, and Organizational Behavior and Human Decision Processes.
Schaumberg ...
Blocking a little-known protein may offer new hope for devastating lung disease
2025-07-15
New York, NY, July 15, 2025—Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have identified a previously overlooked protein, Epac1, as a key driver of idiopathic pulmonary fibrosis (IPF), a chronic and progressive lung-scarring disease. Their findings, demonstrated across cell cultures, preclinical models, and samples of human lung tissue, show that blocking Epac1 can slow the progression of the disease.
Published in the July 7 online issue of European Respiratory ...
Medieval medicine was smarter than you think – and weirdly similar to TikTok trends
2025-07-15
It turns out the Dark Ages weren’t all that dark! According to new research, medieval medicine was way more sophisticated than previously thought, and some of its remedies are trending today on TikTok.
A new international research project featuring faculty at Binghamton University, State University of New York reveals that people in the Middle Ages weren’t cooped up in castles, wallowing in superstition. They were developing health practices based on the best knowledge they had at the time – some of which mirror modern wellness trends.
“People were engaging with medicine on a much broader scale than had previously ...
FAU receives NIH grant to investigate amphetamine addiction
2025-07-15
Lucia Carvelli, Ph.D., associate professor of neuroscience at Florida Atlantic University’s Harriet L. Wilkes Honors College and a member of the FAU Stiles-Nicholson Brain Institute, has received a $571,675 grant from the National Institutes of Health to advance critical research into how amphetamines affect brain function. Her work could pave the way for new therapies targeting substance use disorders and dopamine-related neurological conditions such as ADHD.
Amphetamine and its derivatives – including methamphetamine – are among the most widely abused drugs worldwide. In the United States alone, more than 32,000 ...
Realizing on-site carbon nanotube photo-thermoelectric imaging
2025-07-15
Summary
Led by Assistant Professor Kou Li, a research group in Chuo University, Japan, has developed chemically enriched photo-thermoelectric (PTE) imagers using semiconducting carbon nanotube (CNT) films, resulting in the achievement of enhanced response intensity and noise reduction, that enables efficient remote and on-site inspections, according to a recent paper publication in Communications Materials. CNT film-based PTE imagers are crucial for multimodal non-destructive inspection, but conventional device ...
Most of us love memes. But are they a form of comics?
2025-07-15
COLUMBUS, Ohio – Once upon a time – way back in the twentieth century – people got their laughs from reading comics in the newspaper. Today, many of us get our chuckles by seeing (and sharing) humorous memes online.
But are these two cultural phenomena really that different? In a new article, comics scholar Michelle Ann Abate argues that memes are an important new type of digital comic.
“Memes use a lot of the same visual and verbal elements that go into a comic, and those elements function in a very similar way. So yes, memes ...
Novel biosensor allows real-time monitoring of sucrose uptake in plants
2025-07-15
Sucrose is a vital energy source in plants. It also drives growth and serves as an important signaling molecule during stress and development. Sucrose is a key product of photosynthesis and the primary form of sugar used for long-distance transport in plants. As such, its movement through plant tissues reveals much about its internal state. Yet, despite its importance, tracking sucrose in real time within living plants remains a persistent challenge.
One major challenge is the limited availability of in vivo sensors capable of capturing subtle physiological events, such as the movement of sucrose through plant tissues. Current ...
Korea University researchers reveal revealing how WEE1 drives cancer resistance to immunotherapy
2025-07-15
Immune checkpoints are regulatory proteins that prevent the immune system from attacking healthy tissues. Some cancer cells exploit these checkpoints to avoid immune detection. Immune checkpoint blockade (ICB)—a therapy that uses antibodies to block these deceptive signals—can unleash the immune system to destroy cancer.
However, a major challenge in oncology remains: why do some tumors resist ICB?
In a landmark study, researchers from Korea University have discovered a surprising answer: the protein WEE1, traditionally known as a cell cycle regulator and tumor suppressor, can paradoxically drive immune resistance when located in the cytoplasm of cancer ...
Pusan National University researchers develop breakthrough deep learning model that enhances handheld 3D medical imaging
2025-07-15
Ultrasound (US) imaging is a widely employed diagnostic tool used for real-time imaging of various organs and tissues using ultrasonic sound waves. The waves are sent into the body, and images are created based on how the waves reflect off internal tissues and organs. It is used for guiding many medical procedures, including biopsies and injections, and is important for dynamic monitoring of blood vessels. When the US is combined with photoacoustic (PA) imaging, where laser light pulses are used to produce sound waves in tissues, the resulting ...